% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Dapper:299818,
author = {H. Dapper and C. Rudroff and P. Linde and J. Rosenbrock and
J. Schmitz and S. Ferdinandus and K. Jablonska and D.
Martin$^*$ and C. Rödel$^*$ and E. Fokas},
title = {{R}adiation therapy in anal high-grade squamous
intraepithelial lesions-a pattern of care analysis in
{G}erman-speaking countries.},
journal = {Strahlentherapie und Onkologie},
volume = {201},
issn = {0179-7158},
address = {Heidelberg},
publisher = {Springer Medizin},
reportid = {DKFZ-2025-00555},
pages = {699–705},
year = {2025},
note = {Volume 201, pages 699–705, (2025)},
abstract = {High-grade squamous intraepithelial lesions (HSIL) of the
anal region are recognized as precursor lesions to squamous
cell carcinoma of the anus (SCCA), especially in individuals
infected with the human papillomavirus (HPV). Although
recent studies indicate that treating HSIL can reduce
progression to SCCA, optimal management strategies remain
undefined. High recurrence rates and treatment-associated
morbidities underscore the need for effective therapeutic
options.A survey among radiation oncologists in Germany was
conducted between September and October 2024, covering
clinical practice settings, the frequency of HSIL cases,
experience with radiotherapy, reasons for radiotherapy
inquiries, treatment indications, and concurrent therapies.A
total of 58 radiation oncologists participated in the
survey, with 37 $(63.8\%)$ reporting inquiries about
radiotherapy for HSIL, primarily for patients with multiple
recurrences. Radiotherapy was generally considered an
appropriate option, particularly for recurrent cases where
other treatments posed risks, especially complications or
worsening of anorectal function after local excision.
However, only half of the respondents (29) had prior
experience with treating anal HSIL and rated radiotherapy
outcomes as good or very good. Most respondents indicated a
preference for treating only the local area (i.e., excluding
lymphatic drainage pathways) to a total dose of 40-50
Gy.Recurrent anal HSIL presents a major challenge for
patients, with no established effective treatment standards
available. Radiotherapy is frequently requested and
administered, showing promising preliminary outcomes.
Clinical studies are warranted to evaluate the effectiveness
and tolerability of radiotherapy in patients with anal
HSIL.},
keywords = {Anal high-grade squamous intraepithelial lesions (HSIL)
(Other) / Pattern of care (Other) / Radiation therapy
(Other) / Radiotherapy (Other)},
cin = {FM01},
ddc = {610},
cid = {I:(DE-He78)FM01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40053135},
doi = {10.1007/s00066-025-02380-5},
url = {https://inrepo02.dkfz.de/record/299818},
}